Histone methyltransferase SUV420H1/KMT5B contributes to poor prognosis in hepatocellular carcinoma.
Kato H, Hayami S, Ueno M, Suzaki N, Nakamura M, Yoshimura T, Miyamoto A, Shigekawa Y, Okada KI, Miyazawa M, Kitahata Y, Ehata S, Hamamoto R, Yamaue H, Kawai M.
Kato H, et al.
Cancer Sci. 2024 Feb;115(2):385-400. doi: 10.1111/cas.16038. Epub 2023 Dec 11.
Cancer Sci. 2024.
PMID: 38082550
Free PMC article.